Rank | Gene Set | Z-score |
---|---|---|
1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.84519360 |
2 | L-phenylalanine metabolic process (GO:0006558) | 4.84519360 |
3 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.56002837 |
4 | glycine metabolic process (GO:0006544) | 4.55876265 |
5 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 4.38446587 |
6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.33424996 |
7 | L-phenylalanine catabolic process (GO:0006559) | 4.33424996 |
8 | protein localization to endosome (GO:0036010) | 4.27049259 |
9 | regulation of cholesterol esterification (GO:0010872) | 4.14948273 |
10 | DNA deamination (GO:0045006) | 4.07534688 |
11 | viral transcription (GO:0019083) | 4.03660472 |
12 | cysteine metabolic process (GO:0006534) | 3.95003779 |
13 | sulfur amino acid catabolic process (GO:0000098) | 3.93528529 |
14 | glyoxylate metabolic process (GO:0046487) | 3.90858615 |
15 | serine family amino acid biosynthetic process (GO:0009070) | 3.85312064 |
16 | lysine catabolic process (GO:0006554) | 3.81801385 |
17 | lysine metabolic process (GO:0006553) | 3.81801385 |
18 | translational termination (GO:0006415) | 3.81147936 |
19 | serine family amino acid metabolic process (GO:0009069) | 3.80032185 |
20 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.75128018 |
21 | serine family amino acid catabolic process (GO:0009071) | 3.71861062 |
22 | apoptotic process involved in morphogenesis (GO:0060561) | 3.69872000 |
23 | mannose metabolic process (GO:0006013) | 3.64639936 |
24 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.60972724 |
25 | barbed-end actin filament capping (GO:0051016) | 3.58306525 |
26 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 3.57729476 |
27 | aromatic amino acid family catabolic process (GO:0009074) | 3.53486216 |
28 | 4-hydroxyproline metabolic process (GO:0019471) | 3.53153964 |
29 | translational elongation (GO:0006414) | 3.51126392 |
30 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.45852567 |
31 | negative regulation of cholesterol transport (GO:0032375) | 3.43549454 |
32 | negative regulation of sterol transport (GO:0032372) | 3.43549454 |
33 | regulation of cholesterol homeostasis (GO:2000188) | 3.41898557 |
34 | activation of Rac GTPase activity (GO:0032863) | 3.41517139 |
35 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.41340147 |
36 | negative regulation of fibrinolysis (GO:0051918) | 3.37688248 |
37 | L-serine metabolic process (GO:0006563) | 3.37262055 |
38 | folic acid metabolic process (GO:0046655) | 3.36848581 |
39 | modulation by symbiont of host cellular process (GO:0044068) | 3.34150449 |
40 | protein targeting to ER (GO:0045047) | 3.33360540 |
41 | kynurenine metabolic process (GO:0070189) | 3.31699646 |
42 | cotranslational protein targeting to membrane (GO:0006613) | 3.28642290 |
43 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.27613551 |
44 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.24884681 |
45 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.24884681 |
46 | intestinal cholesterol absorption (GO:0030299) | 3.24614718 |
47 | proline biosynthetic process (GO:0006561) | 3.24402706 |
48 | maternal placenta development (GO:0001893) | 3.23385359 |
49 | cell-substrate adherens junction assembly (GO:0007045) | 3.20782882 |
50 | focal adhesion assembly (GO:0048041) | 3.20782882 |
51 | heme biosynthetic process (GO:0006783) | 3.20498627 |
52 | positive regulation of histone deacetylation (GO:0031065) | 3.18226712 |
53 | adherens junction assembly (GO:0034333) | 3.17699278 |
54 | pentose-phosphate shunt (GO:0006098) | 3.17286365 |
55 | modulation by virus of host process (GO:0019054) | 3.17009745 |
56 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.16510667 |
57 | * regulation of early endosome to late endosome transport (GO:2000641) | 3.15851334 |
58 | protein localization to endoplasmic reticulum (GO:0070972) | 3.15079613 |
59 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.12557006 |
60 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.10410794 |
61 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.10318881 |
62 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.10265569 |
63 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 3.10126466 |
64 | pteridine-containing compound biosynthetic process (GO:0042559) | 3.09372370 |
65 | activation of MAPKKK activity (GO:0000185) | 3.08658311 |
66 | amino-acid betaine metabolic process (GO:0006577) | 3.05212684 |
67 | translational initiation (GO:0006413) | 3.04955605 |
68 | viral life cycle (GO:0019058) | 3.03544822 |
69 | proline metabolic process (GO:0006560) | 3.03052147 |
70 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.02551754 |
71 | cell-cell junction maintenance (GO:0045217) | 3.02427624 |
72 | alpha-linolenic acid metabolic process (GO:0036109) | 3.02059181 |
73 | cellular ketone body metabolic process (GO:0046950) | 3.00008192 |
74 | aspartate family amino acid catabolic process (GO:0009068) | 2.98041850 |
75 | heme transport (GO:0015886) | 2.96445481 |
76 | regulation of fibrinolysis (GO:0051917) | 2.96174671 |
77 | regulation of triglyceride catabolic process (GO:0010896) | 2.96161682 |
78 | stress fiber assembly (GO:0043149) | 2.93971849 |
79 | NIK/NF-kappaB signaling (GO:0038061) | 2.92961702 |
80 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling | 2.92331985 |
81 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.91925206 |
82 | protein carboxylation (GO:0018214) | 2.91925206 |
83 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.91406923 |
84 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.91406923 |
85 | modulation by symbiont of host immune response (GO:0052553) | 2.91406923 |
86 | positive regulation by symbiont of host defense response (GO:0052509) | 2.91406923 |
87 | modulation by symbiont of host defense response (GO:0052031) | 2.91406923 |
88 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.91406923 |
89 | 2-oxoglutarate metabolic process (GO:0006103) | 2.91326806 |
90 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.90997398 |
91 | intestinal absorption (GO:0050892) | 2.90129720 |
92 | Golgi transport vesicle coating (GO:0048200) | 2.89723129 |
93 | COPI coating of Golgi vesicle (GO:0048205) | 2.89723129 |
94 | cellular modified amino acid catabolic process (GO:0042219) | 2.89677779 |
95 | aromatic amino acid family metabolic process (GO:0009072) | 2.88954446 |
96 | protein retention in ER lumen (GO:0006621) | 2.87277836 |
97 | indole-containing compound catabolic process (GO:0042436) | 2.86590187 |
98 | indolalkylamine catabolic process (GO:0046218) | 2.86590187 |
99 | tryptophan catabolic process (GO:0006569) | 2.86590187 |
100 | nucleoside salvage (GO:0043174) | 2.86229695 |
101 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.85907523 |
102 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.85762692 |
103 | adhesion of symbiont to host (GO:0044406) | 2.85595596 |
104 | cellular protein complex disassembly (GO:0043624) | 2.83965269 |
105 | NADPH regeneration (GO:0006740) | 2.83430401 |
106 | negative regulation of cell size (GO:0045792) | 2.82135297 |
107 | homocysteine metabolic process (GO:0050667) | 2.81747284 |
108 | high-density lipoprotein particle remodeling (GO:0034375) | 2.81734126 |
109 | UV protection (GO:0009650) | 2.81666017 |
110 | regulation of defense response to virus by virus (GO:0050690) | 2.81664010 |
111 | porphyrin-containing compound biosynthetic process (GO:0006779) | 2.81280798 |
112 | alpha-amino acid catabolic process (GO:1901606) | 2.81203864 |
113 | ribosomal small subunit biogenesis (GO:0042274) | 2.80625961 |
114 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.80564584 |
115 | positive regulation of protein dephosphorylation (GO:0035307) | 2.80313083 |
116 | urea metabolic process (GO:0019627) | 2.80250868 |
117 | urea cycle (GO:0000050) | 2.80250868 |
118 | plasma lipoprotein particle clearance (GO:0034381) | 2.79984048 |
119 | semaphorin-plexin signaling pathway (GO:0071526) | 2.79407411 |
120 | mitochondrial calcium ion transport (GO:0006851) | 2.78025193 |
121 | regulation of extracellular matrix disassembly (GO:0010715) | 2.77919768 |
122 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.76846691 |
123 | heme metabolic process (GO:0042168) | 2.76812081 |
124 | tooth mineralization (GO:0034505) | 2.74562172 |
125 | purine nucleotide salvage (GO:0032261) | 2.74130445 |
126 | cellular amino acid catabolic process (GO:0009063) | 2.73462159 |
127 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.72483833 |
128 | cholesterol homeostasis (GO:0042632) | 2.72192723 |
129 | nitrogen cycle metabolic process (GO:0071941) | 2.72038725 |
130 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.70799366 |
131 | basement membrane organization (GO:0071711) | 2.70741975 |
132 | virion attachment to host cell (GO:0019062) | 2.70160866 |
133 | adhesion of symbiont to host cell (GO:0044650) | 2.70160866 |
134 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.70155456 |
135 | negative regulation of fatty acid transport (GO:2000192) | 2.69657033 |
136 | regulation of chromatin binding (GO:0035561) | 2.69083555 |
137 | cell-substrate junction assembly (GO:0007044) | 2.68970058 |
138 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.68817542 |
139 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.67102562 |
140 | nucleotide salvage (GO:0043173) | 2.66244281 |
141 | cellular response to virus (GO:0098586) | 2.66205627 |
142 | regulation of protein activation cascade (GO:2000257) | 2.65642150 |
143 | tryptophan metabolic process (GO:0006568) | 2.65406410 |
144 | sterol homeostasis (GO:0055092) | 2.64970707 |
145 | tetrahydrofolate metabolic process (GO:0046653) | 2.64120925 |
146 | negative regulation of viral release from host cell (GO:1902187) | 2.62611321 |
147 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.62391270 |
148 | negative regulation of cell killing (GO:0031342) | 2.62391270 |
149 | fatty acid beta-oxidation (GO:0006635) | 2.62356981 |
150 | folic acid-containing compound metabolic process (GO:0006760) | 2.62096941 |
151 | protein targeting to plasma membrane (GO:0072661) | 2.61856115 |
152 | tricarboxylic acid metabolic process (GO:0072350) | 2.61580956 |
153 | bile acid biosynthetic process (GO:0006699) | 2.61526591 |
154 | ketone body metabolic process (GO:1902224) | 2.61260179 |
155 | protein complex disassembly (GO:0043241) | 2.60691493 |
156 | glucose 6-phosphate metabolic process (GO:0051156) | 2.60595693 |
157 | acylglycerol homeostasis (GO:0055090) | 2.60129086 |
158 | triglyceride homeostasis (GO:0070328) | 2.60129086 |
159 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.59767114 |
160 | response to mercury ion (GO:0046689) | 2.59759370 |
161 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.58525117 |
162 | modulation by virus of host morphology or physiology (GO:0019048) | 2.57361159 |
163 | GDP-mannose metabolic process (GO:0019673) | 2.57007755 |
164 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.56859582 |
165 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 2.53181797 |
166 | positive regulation of receptor recycling (GO:0001921) | 2.50817883 |
167 | pinocytosis (GO:0006907) | 2.49325077 |
168 | glucose catabolic process (GO:0006007) | 2.49180895 |
169 | positive regulation of myotube differentiation (GO:0010831) | 2.48814798 |
170 | positive thymic T cell selection (GO:0045059) | 2.48078348 |
171 | apoptotic process involved in development (GO:1902742) | 2.47953963 |
172 | negative regulation of necroptotic process (GO:0060546) | 2.45538228 |
173 | response to laminar fluid shear stress (GO:0034616) | 2.45513138 |
174 | regulation of ARF GTPase activity (GO:0032312) | 2.43916911 |
175 | regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway | 2.43417104 |
176 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.41571819 |
177 | positive regulation of protein deacetylation (GO:0090312) | 2.41361519 |
178 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059) | 2.40934943 |
179 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.40096947 |
180 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.37389819 |
181 | response to peptidoglycan (GO:0032494) | 2.36758619 |
182 | regulation of necrotic cell death (GO:0010939) | 2.35030257 |
183 | NADH metabolic process (GO:0006734) | 2.34434085 |
184 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.34318130 |
185 | thymic T cell selection (GO:0045061) | 2.33955857 |
186 | signal complex assembly (GO:0007172) | 2.31555030 |
187 | activation of JUN kinase activity (GO:0007257) | 2.30958248 |
188 | embryonic process involved in female pregnancy (GO:0060136) | 2.30844958 |
189 | cortical actin cytoskeleton organization (GO:0030866) | 2.29633742 |
190 | epithelial cell-cell adhesion (GO:0090136) | 2.29474997 |
191 | skin morphogenesis (GO:0043589) | 2.26551238 |
192 | regulation of protein dephosphorylation (GO:0035304) | 2.25355198 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.42531487 |
2 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.49873346 |
3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.48960540 |
4 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.02728554 |
5 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.00744623 |
6 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.50886277 |
7 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.30118212 |
8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.07459751 |
9 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.06994495 |
10 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.06725188 |
11 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.04965882 |
12 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.99300054 |
13 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.97773976 |
14 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.94351797 |
15 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.92009806 |
16 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.91380336 |
17 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.89727885 |
18 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.86429645 |
19 | KDM2B_26808549_Chip-Seq_K562_Human | 1.86208446 |
20 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.83395841 |
21 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.82351104 |
22 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.79123264 |
23 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.76055681 |
24 | MYC_22102868_ChIP-Seq_BL_Human | 1.74280527 |
25 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.72924666 |
26 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.72630565 |
27 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.72423985 |
28 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.67457169 |
29 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.65616525 |
30 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.65357096 |
31 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.63967455 |
32 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.62201212 |
33 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.61068547 |
34 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.60639314 |
35 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.57439826 |
36 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.54132346 |
37 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.53059973 |
38 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.52956797 |
39 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.51161532 |
40 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.49998321 |
41 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.48887509 |
42 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.48529081 |
43 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.47155964 |
44 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.46074249 |
45 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.45996423 |
46 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.45110983 |
47 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.43815924 |
48 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.43724887 |
49 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.43007198 |
50 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.42124465 |
51 | * MAF_26560356_Chip-Seq_TH1_Human | 1.41944515 |
52 | P68_20966046_ChIP-Seq_HELA_Human | 1.40955856 |
53 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.40622541 |
54 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.38379937 |
55 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.37408777 |
56 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.36826276 |
57 | ATF3_27146783_Chip-Seq_COLON_Human | 1.36241301 |
58 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.35329746 |
59 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.35210102 |
60 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.34390500 |
61 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.33079686 |
62 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.32030486 |
63 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.31899784 |
64 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.31427143 |
65 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.31336646 |
66 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.31006179 |
67 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.29277843 |
68 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.29271762 |
69 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.28677586 |
70 | UTX_26944678_Chip-Seq_JUKART_Human | 1.27987144 |
71 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.27185407 |
72 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.27061242 |
73 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27006409 |
74 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.25496844 |
75 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.25472133 |
76 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.25292336 |
77 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.24425898 |
78 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.24224325 |
79 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.24108714 |
80 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.23171816 |
81 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.23114903 |
82 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.22776537 |
83 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.22213824 |
84 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.20502596 |
85 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.20062713 |
86 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.18527518 |
87 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.18297843 |
88 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.17897471 |
89 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.17468697 |
90 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17439688 |
91 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.17439472 |
92 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.16873361 |
93 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.15822921 |
94 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.15408089 |
95 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.14741846 |
96 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.13661011 |
97 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.12262792 |
98 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.12210787 |
99 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.11860423 |
100 | * PHF8_20622854_ChIP-Seq_HELA_Human | 1.11260163 |
101 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.11103948 |
102 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.10916559 |
103 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.10716501 |
104 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.10055069 |
105 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.10002609 |
106 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.09643095 |
107 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.09497536 |
108 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.08888763 |
109 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.08337291 |
110 | * HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.08260012 |
111 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.07273998 |
112 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.07143398 |
113 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.06919696 |
114 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.06746533 |
115 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.06648603 |
116 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.06257966 |
117 | * RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.05571118 |
118 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.05017449 |
119 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 1.03945018 |
120 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.03113355 |
121 | SA1_27219007_Chip-Seq_Bcells_Human | 1.02907938 |
122 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.02806277 |
123 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.02778177 |
124 | * E2F1_20622854_ChIP-Seq_HELA_Human | 1.02768264 |
125 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.01600427 |
126 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.01287304 |
127 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.01174150 |
128 | MAF_26560356_Chip-Seq_TH2_Human | 1.01120834 |
129 | * SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.99449057 |
130 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.97457137 |
131 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.97130965 |
132 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.97087503 |
133 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 0.97076715 |
134 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.96623962 |
135 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.96533259 |
136 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.96000024 |
137 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.95084646 |
138 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.94602416 |
139 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.94442389 |
140 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.94413088 |
141 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.94382588 |
142 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.94325655 |
143 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.94254900 |
144 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.93786269 |
145 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.92991595 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 5.12233527 |
2 | MP0005360_urolithiasis | 5.01142823 |
3 | MP0009840_abnormal_foam_cell | 4.63226120 |
4 | MP0005365_abnormal_bile_salt | 3.51828269 |
5 | MP0003806_abnormal_nucleotide_metabolis | 3.48270669 |
6 | MP0004858_abnormal_nervous_system | 3.47164019 |
7 | MP0005085_abnormal_gallbladder_physiolo | 3.28922203 |
8 | MP0005083_abnormal_biliary_tract | 3.04236657 |
9 | MP0008875_abnormal_xenobiotic_pharmacok | 2.66399891 |
10 | MP0002877_abnormal_melanocyte_morpholog | 2.46104508 |
11 | MP0001666_abnormal_nutrient_absorption | 2.38668163 |
12 | MP0005076_abnormal_cell_differentiation | 2.27611078 |
13 | MP0003705_abnormal_hypodermis_morpholog | 2.24189878 |
14 | MP0003191_abnormal_cellular_cholesterol | 2.21581182 |
15 | MP0005332_abnormal_amino_acid | 2.20870201 |
16 | MP0003436_decreased_susceptibility_to | 2.20666271 |
17 | MP0003172_abnormal_lysosome_physiology | 2.10919380 |
18 | MP0010329_abnormal_lipoprotein_level | 2.07121668 |
19 | MP0005377_hearing/vestibular/ear_phenot | 2.02695947 |
20 | MP0003878_abnormal_ear_physiology | 2.02695947 |
21 | MP0003693_abnormal_embryo_hatching | 1.94260150 |
22 | MP0003656_abnormal_erythrocyte_physiolo | 1.88053669 |
23 | MP0004510_myositis | 1.84766333 |
24 | MP0003252_abnormal_bile_duct | 1.80799103 |
25 | MP0005409_darkened_coat_color | 1.80028802 |
26 | MP0003329_amyloid_beta_deposits | 1.73131713 |
27 | MP0003453_abnormal_keratinocyte_physiol | 1.72768791 |
28 | MP0000609_abnormal_liver_physiology | 1.68378796 |
29 | MP0003566_abnormal_cell_adhesion | 1.66335566 |
30 | MP0009643_abnormal_urine_homeostasis | 1.61089154 |
31 | MP0004233_abnormal_muscle_weight | 1.60249581 |
32 | MP0006036_abnormal_mitochondrial_physio | 1.58545465 |
33 | MP0003195_calcinosis | 1.56752797 |
34 | MP0010234_abnormal_vibrissa_follicle | 1.56258315 |
35 | MP0000685_abnormal_immune_system | 1.52529765 |
36 | MP0005451_abnormal_body_composition | 1.50232147 |
37 | MP0004947_skin_inflammation | 1.49969268 |
38 | MP0003279_aneurysm | 1.49913031 |
39 | MP0004019_abnormal_vitamin_homeostasis | 1.47231348 |
40 | MP0002249_abnormal_larynx_morphology | 1.47037543 |
41 | MP0000858_altered_metastatic_potential | 1.46033193 |
42 | MP0000750_abnormal_muscle_regeneration | 1.45306837 |
43 | MP0005319_abnormal_enzyme/_coenzyme | 1.45046686 |
44 | MP0003091_abnormal_cell_migration | 1.35697173 |
45 | MP0002118_abnormal_lipid_homeostasis | 1.33574269 |
46 | MP0002837_dystrophic_cardiac_calcinosis | 1.33286995 |
47 | MP0005220_abnormal_exocrine_pancreas | 1.29362702 |
48 | MP0003123_paternal_imprinting | 1.28084391 |
49 | MP0003283_abnormal_digestive_organ | 1.27086010 |
50 | MP0001958_emphysema | 1.26998828 |
51 | MP0010030_abnormal_orbit_morphology | 1.25914822 |
52 | MP0005636_abnormal_mineral_homeostasis | 1.24258995 |
53 | MP0000749_muscle_degeneration | 1.23294372 |
54 | MP0005623_abnormal_meninges_morphology | 1.22884321 |
55 | MP0003186_abnormal_redox_activity | 1.21166805 |
56 | MP0002269_muscular_atrophy | 1.16158839 |
57 | MP0000013_abnormal_adipose_tissue | 1.15484579 |
58 | MP0005058_abnormal_lysosome_morphology | 1.15339954 |
59 | MP0001790_abnormal_immune_system | 1.13436521 |
60 | MP0005387_immune_system_phenotype | 1.13436521 |
61 | MP0001873_stomach_inflammation | 1.13115843 |
62 | MP0005025_abnormal_response_to | 1.11955772 |
63 | MP0000604_amyloidosis | 1.11633103 |
64 | MP0005670_abnormal_white_adipose | 1.10684173 |
65 | MP0008438_abnormal_cutaneous_collagen | 1.10654937 |
66 | MP0003879_abnormal_hair_cell | 1.10463389 |
67 | MP0002998_abnormal_bone_remodeling | 1.09123235 |
68 | MP0000598_abnormal_liver_morphology | 1.07437814 |
69 | MP0005666_abnormal_adipose_tissue | 1.06113333 |
70 | MP0004130_abnormal_muscle_cell | 1.05063664 |
71 | MP0009053_abnormal_anal_canal | 1.04532412 |
72 | MP0001533_abnormal_skeleton_physiology | 1.04139811 |
73 | MP0004185_abnormal_adipocyte_glucose | 1.04087149 |
74 | MP0000747_muscle_weakness | 1.04076930 |
75 | MP0002419_abnormal_innate_immunity | 1.03901354 |
76 | MP0003075_altered_response_to | 1.03140996 |
77 | MP0004043_abnormal_pH_regulation | 1.02498743 |
78 | MP0002653_abnormal_ependyma_morphology | 1.02234603 |
79 | MP0003868_abnormal_feces_composition | 1.00972097 |
80 | MP0005501_abnormal_skin_physiology | 0.99005122 |
81 | MP0000681_abnormal_thyroid_gland | 0.98398518 |
82 | MP0003646_muscle_fatigue | 0.97834799 |
83 | MP0004957_abnormal_blastocyst_morpholog | 0.97715111 |
84 | MP0001849_ear_inflammation | 0.96358872 |
85 | MP0000462_abnormal_digestive_system | 0.95922567 |
86 | MP0005375_adipose_tissue_phenotype | 0.95261887 |
87 | MP0001756_abnormal_urination | 0.93920025 |
88 | MP0006035_abnormal_mitochondrial_morpho | 0.93693989 |
89 | MP0000358_abnormal_cell_content/ | 0.92413214 |
90 | MP0005000_abnormal_immune_tolerance | 0.91472885 |
91 | MP0010155_abnormal_intestine_physiology | 0.90741704 |
92 | MP0000751_myopathy | 0.90146367 |
93 | MP0002060_abnormal_skin_morphology | 0.89957951 |
94 | MP0003111_abnormal_nucleus_morphology | 0.89584068 |
95 | MP0000767_abnormal_smooth_muscle | 0.87990744 |
96 | MP0000003_abnormal_adipose_tissue | 0.86722367 |
97 | MP0005464_abnormal_platelet_physiology | 0.86205250 |
98 | MP0005330_cardiomyopathy | 0.85628344 |
99 | MP0001663_abnormal_digestive_system | 0.85073985 |
100 | MP0003183_abnormal_peptide_metabolism | 0.84724172 |
101 | MP0005390_skeleton_phenotype | 0.84032726 |
102 | MP0003303_peritoneal_inflammation | 0.83599460 |
103 | MP0002138_abnormal_hepatobiliary_system | 0.83143066 |
104 | MP0001542_abnormal_bone_strength | 0.82780419 |
105 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.81910870 |
106 | MP0003763_abnormal_thymus_physiology | 0.81762029 |
107 | MP0005084_abnormal_gallbladder_morpholo | 0.81413606 |
108 | MP0009672_abnormal_birth_weight | 0.80426647 |
109 | MP0005166_decreased_susceptibility_to | 0.79854250 |
110 | MP0000759_abnormal_skeletal_muscle | 0.79625283 |
111 | MP0002796_impaired_skin_barrier | 0.79311537 |
112 | MP0001730_embryonic_growth_arrest | 0.79028053 |
113 | MP0000490_abnormal_crypts_of | 0.78010045 |
114 | MP0009333_abnormal_splenocyte_physiolog | 0.77662478 |
115 | MP0001944_abnormal_pancreas_morphology | 0.77639528 |
116 | MP0002420_abnormal_adaptive_immunity | 0.75889617 |
117 | MP0001819_abnormal_immune_cell | 0.75854313 |
118 | MP0008874_decreased_physiological_sensi | 0.75817285 |
119 | MP0009931_abnormal_skin_appearance | 0.75781406 |
120 | MP0004859_abnormal_synaptic_plasticity | 0.74079608 |
121 | MP0000343_altered_response_to | 0.73478740 |
122 | MP0009278_abnormal_bone_marrow | 0.73309121 |
123 | MP0001835_abnormal_antigen_presentation | 0.73173806 |
124 | MP0002148_abnormal_hypersensitivity_rea | 0.72553954 |
125 | MP0002896_abnormal_bone_mineralization | 0.72294745 |
126 | MP0004087_abnormal_muscle_fiber | 0.71728268 |
127 | MP0002723_abnormal_immune_serum | 0.71514956 |
128 | MP0009642_abnormal_blood_homeostasis | 0.71452387 |
129 | MP0000537_abnormal_urethra_morphology | 0.71111849 |
130 | MP0005257_abnormal_intraocular_pressure | 0.71006991 |
131 | MP0002234_abnormal_pharynx_morphology | 0.70254810 |
132 | MP0003634_abnormal_glial_cell | 0.70137000 |
133 | MP0002452_abnormal_antigen_presenting | 0.68572523 |
134 | MP0003718_maternal_effect | 0.68272334 |
135 | MP0004381_abnormal_hair_follicle | 0.67774234 |
136 | MP0000467_abnormal_esophagus_morphology | 0.67632616 |
137 | MP0004272_abnormal_basement_membrane | 0.67391162 |
138 | MP0004808_abnormal_hematopoietic_stem | 0.66762341 |
139 | MP0002254_reproductive_system_inflammat | 0.65595812 |
140 | MP0000477_abnormal_intestine_morphology | 0.65109647 |
141 | MP0002398_abnormal_bone_marrow | 0.64951777 |
142 | MP0002971_abnormal_brown_adipose | 0.64699748 |
143 | MP0002078_abnormal_glucose_homeostasis | 0.64413511 |
144 | MP0002080_prenatal_lethality | 0.64156524 |
145 | MP0001800_abnormal_humoral_immune | 0.64119863 |
146 | MP0003119_abnormal_digestive_system | 0.63265632 |
147 | MP0003300_gastrointestinal_ulcer | 0.63047222 |
148 | MP0009379_abnormal_foot_pigmentation | 0.62287930 |
149 | MP0000733_abnormal_muscle_development | 0.62017142 |
150 | MP0005023_abnormal_wound_healing | 0.61356714 |
151 | MP0001348_abnormal_lacrimal_gland | 0.60352664 |
152 | MP0003315_abnormal_perineum_morphology | 0.59955441 |
153 | MP0005381_digestive/alimentary_phenotyp | 0.59669303 |
154 | MP0008469_abnormal_protein_level | 0.59066584 |
155 | MP0003011_delayed_dark_adaptation | 0.58342319 |
156 | MP0002089_abnormal_postnatal_growth/wei | 0.57494175 |
157 | MP0000678_abnormal_parathyroid_gland | 0.56724411 |
158 | MP0008260_abnormal_autophagy | 0.56181735 |
159 | MP0002136_abnormal_kidney_physiology | 0.56124489 |
160 | MP0001661_extended_life_span | 0.55866437 |
161 | MP0008932_abnormal_embryonic_tissue | 0.55015582 |
162 | MP0002111_abnormal_tail_morphology | 0.54702383 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.77761802 |
2 | Xanthomatosis (HP:0000991) | 4.12491488 |
3 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.79638588 |
4 | Hypobetalipoproteinemia (HP:0003563) | 3.72219951 |
5 | Deep venous thrombosis (HP:0002625) | 3.50997842 |
6 | Hyperglycinuria (HP:0003108) | 3.40643000 |
7 | Hypoglycemic coma (HP:0001325) | 3.38736533 |
8 | Hyperacusis (HP:0010780) | 3.38076851 |
9 | Late onset (HP:0003584) | 3.30569913 |
10 | Hyperglycinemia (HP:0002154) | 3.25521216 |
11 | Hyperammonemia (HP:0001987) | 3.22717585 |
12 | Ketosis (HP:0001946) | 3.18968370 |
13 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.18730713 |
14 | Abnormality of glycine metabolism (HP:0010895) | 3.18730713 |
15 | Intrahepatic cholestasis (HP:0001406) | 3.18339337 |
16 | Vertebral compression fractures (HP:0002953) | 3.18084810 |
17 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.08506848 |
18 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.00261769 |
19 | Dicarboxylic aciduria (HP:0003215) | 3.00261769 |
20 | Hyperlipoproteinemia (HP:0010980) | 2.97988785 |
21 | Hypolipoproteinemia (HP:0010981) | 2.94943873 |
22 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.91707239 |
23 | Progressive muscle weakness (HP:0003323) | 2.91376248 |
24 | Distal lower limb muscle weakness (HP:0009053) | 2.82210401 |
25 | Gout (HP:0001997) | 2.81400810 |
26 | Distal lower limb amyotrophy (HP:0008944) | 2.78248812 |
27 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.75427652 |
28 | Type 1 muscle fiber predominance (HP:0003803) | 2.71975412 |
29 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.71403382 |
30 | Cerebral aneurysm (HP:0004944) | 2.69871862 |
31 | Ileus (HP:0002595) | 2.69617537 |
32 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.67673161 |
33 | Increased variability in muscle fiber diameter (HP:0003557) | 2.67142168 |
34 | Prolonged partial thromboplastin time (HP:0003645) | 2.65478678 |
35 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.64018783 |
36 | Hepatic necrosis (HP:0002605) | 2.61921644 |
37 | Distal upper limb amyotrophy (HP:0007149) | 2.61497095 |
38 | Upper limb amyotrophy (HP:0009129) | 2.61497095 |
39 | Obstructive sleep apnea (HP:0002870) | 2.59020216 |
40 | Rhabdomyolysis (HP:0003201) | 2.58956168 |
41 | Hypoalphalipoproteinemia (HP:0003233) | 2.57761421 |
42 | Thin bony cortex (HP:0002753) | 2.54592007 |
43 | Myoglobinuria (HP:0002913) | 2.54226303 |
44 | Myopathic facies (HP:0002058) | 2.52805450 |
45 | Multiple enchondromatosis (HP:0005701) | 2.52619563 |
46 | Abnormality of the Achilles tendon (HP:0005109) | 2.52078290 |
47 | Generalized aminoaciduria (HP:0002909) | 2.51049691 |
48 | Macrocytic anemia (HP:0001972) | 2.51000325 |
49 | Ketoacidosis (HP:0001993) | 2.49322925 |
50 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.49287302 |
51 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.47031079 |
52 | Stridor (HP:0010307) | 2.46739520 |
53 | Disproportionate tall stature (HP:0001519) | 2.46203977 |
54 | Abnormal number of erythroid precursors (HP:0012131) | 2.45459836 |
55 | Fragile skin (HP:0001030) | 2.44806437 |
56 | Lethargy (HP:0001254) | 2.41892518 |
57 | Increased serum ferritin (HP:0003281) | 2.40844932 |
58 | Abnormal cartilage morphology (HP:0002763) | 2.38047921 |
59 | Broad face (HP:0000283) | 2.37112547 |
60 | Reticulocytosis (HP:0001923) | 2.36722555 |
61 | Ulnar bowing (HP:0003031) | 2.31934819 |
62 | Difficulty climbing stairs (HP:0003551) | 2.31424676 |
63 | Premature rupture of membranes (HP:0001788) | 2.30026811 |
64 | Cellulitis (HP:0100658) | 2.28759058 |
65 | Insomnia (HP:0100785) | 2.27189856 |
66 | Achilles tendon contracture (HP:0001771) | 2.26784047 |
67 | Protrusio acetabuli (HP:0003179) | 2.26568677 |
68 | Eczematoid dermatitis (HP:0000976) | 2.25558117 |
69 | Hyperbilirubinemia (HP:0002904) | 2.25396393 |
70 | Spinal rigidity (HP:0003306) | 2.25241246 |
71 | Hyperparathyroidism (HP:0000843) | 2.23654957 |
72 | Emphysema (HP:0002097) | 2.23318033 |
73 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.22899552 |
74 | Brushfield spots (HP:0001088) | 2.20398107 |
75 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.19518824 |
76 | Mitral regurgitation (HP:0001653) | 2.19384421 |
77 | Abnormality of the thoracic spine (HP:0100711) | 2.19106530 |
78 | Polycythemia (HP:0001901) | 2.19042357 |
79 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.17998132 |
80 | Abnormality of reticulocytes (HP:0004312) | 2.17596440 |
81 | Axonal loss (HP:0003447) | 2.16943578 |
82 | Opisthotonus (HP:0002179) | 2.15549341 |
83 | Hepatocellular necrosis (HP:0001404) | 2.14195755 |
84 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.13429655 |
85 | Genu recurvatum (HP:0002816) | 2.12750978 |
86 | Abnormality of the intrinsic pathway (HP:0010989) | 2.12698683 |
87 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.11836765 |
88 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.11836765 |
89 | Abnormality of glycolipid metabolism (HP:0010969) | 2.11836765 |
90 | Back pain (HP:0003418) | 2.11270017 |
91 | Malnutrition (HP:0004395) | 2.10974107 |
92 | Abnormality of serum amino acid levels (HP:0003112) | 2.09447392 |
93 | Dysostosis multiplex (HP:0000943) | 2.09266035 |
94 | Exercise-induced myalgia (HP:0003738) | 2.08851629 |
95 | Abnormality of nucleobase metabolism (HP:0010932) | 2.08329793 |
96 | Shallow orbits (HP:0000586) | 2.07702752 |
97 | Abnormality of the common coagulation pathway (HP:0010990) | 2.07500279 |
98 | Abnormality of iron homeostasis (HP:0011031) | 2.06408166 |
99 | Poikilocytosis (HP:0004447) | 2.06283167 |
100 | Cervical subluxation (HP:0003308) | 2.06282864 |
101 | Polygenic inheritance (HP:0010982) | 2.04707601 |
102 | Blue sclerae (HP:0000592) | 2.03689245 |
103 | Decreased subcutaneous fat (HP:0001002) | 2.03355212 |
104 | Increased cerebral lipofuscin (HP:0011813) | 2.03170876 |
105 | Hemorrhage of the eye (HP:0011885) | 2.02937397 |
106 | Hypercortisolism (HP:0001578) | 2.02786493 |
107 | Bulbar palsy (HP:0001283) | 2.02107268 |
108 | Trismus (HP:0000211) | 2.01331517 |
109 | Abnormality of purine metabolism (HP:0004352) | 2.01044913 |
110 | Acanthocytosis (HP:0001927) | 2.00805804 |
111 | Ankle contracture (HP:0006466) | 1.96851331 |
112 | Slender build (HP:0001533) | 1.96841790 |
113 | Round ear (HP:0100830) | 1.96523572 |
114 | CNS demyelination (HP:0007305) | 1.95955694 |
115 | Rectal prolapse (HP:0002035) | 1.95407286 |
116 | Cerebral inclusion bodies (HP:0100314) | 1.95247177 |
117 | Metabolic acidosis (HP:0001942) | 1.94726698 |
118 | Flat acetabular roof (HP:0003180) | 1.94498298 |
119 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.94371710 |
120 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.94371710 |
121 | J-shaped sella turcica (HP:0002680) | 1.93951420 |
122 | Biconcave vertebral bodies (HP:0004586) | 1.93906905 |
123 | Gastrointestinal stroma tumor (HP:0100723) | 1.93222701 |
124 | Cholelithiasis (HP:0001081) | 1.92529074 |
125 | Thoracic kyphosis (HP:0002942) | 1.92520767 |
126 | Irritability (HP:0000737) | 1.92268919 |
127 | Cerebral edema (HP:0002181) | 1.91736091 |
128 | Ventricular tachycardia (HP:0004756) | 1.91025667 |
129 | Bladder diverticulum (HP:0000015) | 1.90543440 |
130 | Supranuclear gaze palsy (HP:0000605) | 1.90031298 |
131 | Asymmetric septal hypertrophy (HP:0001670) | 1.89113141 |
132 | Easy fatigability (HP:0003388) | 1.88337047 |
133 | Abnormality of methionine metabolism (HP:0010901) | 1.88303569 |
134 | Chronic obstructive pulmonary disease (HP:0006510) | 1.88023706 |
135 | Obstructive lung disease (HP:0006536) | 1.88023706 |
136 | Lower limb amyotrophy (HP:0007210) | 1.87305890 |
137 | Abnormality of subcutaneous fat tissue (HP:0001001) | 1.87034984 |
138 | Broad distal phalanx of finger (HP:0009836) | 1.86299728 |
139 | Insulin resistance (HP:0000855) | 1.86144773 |
140 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.85288404 |
141 | Delayed CNS myelination (HP:0002188) | 1.85167155 |
142 | Generalized amyotrophy (HP:0003700) | 1.84960681 |
143 | Glycosuria (HP:0003076) | 1.84690275 |
144 | Abnormality of urine glucose concentration (HP:0011016) | 1.84690275 |
145 | Complement deficiency (HP:0004431) | 1.83989568 |
146 | Abnormality of macrophages (HP:0004311) | 1.83844012 |
147 | Reticulocytopenia (HP:0001896) | 1.83594456 |
148 | Microretrognathia (HP:0000308) | 1.83029212 |
149 | Abnormal gallbladder physiology (HP:0012438) | 1.82684791 |
150 | Cholecystitis (HP:0001082) | 1.82684791 |
151 | Testicular atrophy (HP:0000029) | 1.81605161 |
152 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.81509686 |
153 | Fat malabsorption (HP:0002630) | 1.81388234 |
154 | Abnormality of the nasal mucosa (HP:0000433) | 1.81080277 |
155 | Hand muscle atrophy (HP:0009130) | 1.80944961 |
156 | Hepatocellular carcinoma (HP:0001402) | 1.80769030 |
157 | Ragged-red muscle fibers (HP:0003200) | 1.80729538 |
158 | Turricephaly (HP:0000262) | 1.80358736 |
159 | Elbow flexion contracture (HP:0002987) | 1.80036733 |
160 | Ulnar deviation of the wrist (HP:0003049) | 1.79846449 |
161 | Vomiting (HP:0002013) | 1.78525432 |
162 | Oral leukoplakia (HP:0002745) | 1.78409635 |
163 | Abnormal gallbladder morphology (HP:0012437) | 1.78105794 |
164 | Neonatal onset (HP:0003623) | 1.77855069 |
165 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.77194255 |
166 | Global brain atrophy (HP:0002283) | 1.77086183 |
167 | Abnormality of complement system (HP:0005339) | 1.76580639 |
168 | Upper motor neuron abnormality (HP:0002127) | 1.76569301 |
169 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.74705978 |
170 | Hypercholesterolemia (HP:0003124) | 1.74481598 |
171 | Entropion (HP:0000621) | 1.74427901 |
172 | Aneurysm (HP:0002617) | 1.74284193 |
173 | Neurofibrillary tangles (HP:0002185) | 1.74246208 |
174 | Joint hemorrhage (HP:0005261) | 1.73801540 |
175 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.72998382 |
176 | Increased connective tissue (HP:0009025) | 1.72141823 |
177 | Hypertensive crisis (HP:0100735) | 1.71767243 |
178 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.70719817 |
179 | Dilatation of the ascending aorta (HP:0005111) | 1.69018316 |
180 | Hyperthyroidism (HP:0000836) | 1.68703623 |
181 | Premature skin wrinkling (HP:0100678) | 1.62478117 |
182 | Hypercalcemia (HP:0003072) | 1.62085019 |
183 | Visual hallucinations (HP:0002367) | 1.61764361 |
184 | Short nail (HP:0001799) | 1.61292268 |
185 | Truncus arteriosus (HP:0001660) | 1.60788342 |
186 | Coxa vara (HP:0002812) | 1.59997006 |
187 | Atrophic scars (HP:0001075) | 1.58783879 |
188 | Pathologic fracture (HP:0002756) | 1.58140920 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TRIB3 | 4.48206478 |
2 | ERN1 | 3.88925790 |
3 | BCKDK | 3.84272513 |
4 | NME2 | 3.75045097 |
5 | SMG1 | 3.44086584 |
6 | MAP3K10 | 3.34894436 |
7 | PRPF4B | 3.15338521 |
8 | TESK2 | 3.09922577 |
9 | BUB1 | 2.72723840 |
10 | PKN2 | 2.55103592 |
11 | TLK1 | 2.36399475 |
12 | MAP3K11 | 2.22591096 |
13 | BLK | 1.87770729 |
14 | RIPK1 | 1.84490695 |
15 | TESK1 | 1.82634132 |
16 | DYRK3 | 1.80241807 |
17 | PIM2 | 1.68574700 |
18 | TTN | 1.57716632 |
19 | MAP3K13 | 1.56817130 |
20 | STK16 | 1.53356381 |
21 | KDR | 1.53103792 |
22 | EEF2K | 1.50248960 |
23 | PTK6 | 1.50062295 |
24 | ICK | 1.46997041 |
25 | FGFR4 | 1.39119185 |
26 | LIMK1 | 1.38940000 |
27 | EPHA2 | 1.37646427 |
28 | SIK1 | 1.35872549 |
29 | KSR2 | 1.34109302 |
30 | TAOK1 | 1.27952524 |
31 | RPS6KA2 | 1.27495718 |
32 | PAK4 | 1.27486584 |
33 | LRRK2 | 1.26437499 |
34 | FLT3 | 1.24356281 |
35 | RIPK4 | 1.23875377 |
36 | DYRK1B | 1.22435795 |
37 | RPS6KA4 | 1.21715269 |
38 | NME1 | 1.21294738 |
39 | MARK2 | 1.21069803 |
40 | IRAK4 | 1.19038390 |
41 | MST1R | 1.17060292 |
42 | NEK2 | 1.16788595 |
43 | * MAP2K2 | 1.16661297 |
44 | CDK12 | 1.15963768 |
45 | SCYL2 | 1.15495576 |
46 | EIF2AK1 | 1.14175297 |
47 | PRKD3 | 1.08267588 |
48 | CDC42BPA | 1.06261731 |
49 | MAPKAPK3 | 1.04483988 |
50 | ILK | 1.01100221 |
51 | DAPK3 | 0.99946950 |
52 | RPS6KC1 | 0.94995488 |
53 | RPS6KL1 | 0.94995488 |
54 | DDR2 | 0.92462011 |
55 | ABL2 | 0.92131938 |
56 | AURKA | 0.90880669 |
57 | LATS2 | 0.90638972 |
58 | MAP4K1 | 0.90266367 |
59 | MAPK11 | 0.89778082 |
60 | PDGFRA | 0.87794232 |
61 | BMX | 0.87536548 |
62 | IRAK2 | 0.86579548 |
63 | TAOK2 | 0.86338621 |
64 | PTK2 | 0.86124508 |
65 | MAP2K3 | 0.86100522 |
66 | MAP3K3 | 0.85592609 |
67 | EPHB1 | 0.85448911 |
68 | WEE1 | 0.85359460 |
69 | HIPK2 | 0.85312806 |
70 | * PDPK1 | 0.84343839 |
71 | SIK2 | 0.83001474 |
72 | PASK | 0.79444255 |
73 | PRKCI | 0.79280005 |
74 | EPHB2 | 0.78299960 |
75 | MOS | 0.77892624 |
76 | RPS6KA6 | 0.77700481 |
77 | PIK3CG | 0.76879411 |
78 | TBK1 | 0.76879029 |
79 | MET | 0.76283584 |
80 | PAK1 | 0.75344398 |
81 | PAK2 | 0.75000325 |
82 | MTOR | 0.74055276 |
83 | MAP3K9 | 0.73158519 |
84 | MAPK12 | 0.70697845 |
85 | ZAP70 | 0.67491787 |
86 | TYRO3 | 0.66205281 |
87 | MAPK15 | 0.65343866 |
88 | RPS6KB2 | 0.64364728 |
89 | GRK6 | 0.64031008 |
90 | NTRK1 | 0.63518622 |
91 | WNK4 | 0.63438464 |
92 | AKT2 | 0.63163870 |
93 | IRAK3 | 0.62942151 |
94 | LMTK2 | 0.62338453 |
95 | CDK7 | 0.62277190 |
96 | DYRK2 | 0.62153646 |
97 | MAP2K1 | 0.58520031 |
98 | CAMKK1 | 0.58132400 |
99 | TNK2 | 0.57436929 |
100 | PAK6 | 0.55695045 |
101 | CDK4 | 0.55647702 |
102 | NEK1 | 0.54623099 |
103 | PRKD1 | 0.54260406 |
104 | ARAF | 0.53338948 |
105 | DMPK | 0.49834975 |
106 | * MAP3K8 | 0.48828780 |
107 | CSK | 0.48630805 |
108 | PINK1 | 0.46478084 |
109 | TYK2 | 0.45924869 |
110 | ERBB2 | 0.44614707 |
111 | STK38 | 0.43931521 |
112 | MAP3K6 | 0.43815277 |
113 | AURKB | 0.43369885 |
114 | * PDK1 | 0.42612275 |
115 | PHKG2 | 0.42469016 |
116 | PHKG1 | 0.42469016 |
117 | JAK3 | 0.41125796 |
118 | CAMK1D | 0.40816798 |
119 | STK10 | 0.38426007 |
120 | RPS6KA1 | 0.37836440 |
121 | MAP3K14 | 0.35804737 |
122 | PRKG2 | 0.35785087 |
123 | PRKCH | 0.35632952 |
124 | MAPKAPK2 | 0.35544316 |
125 | SGK3 | 0.35190319 |
126 | CDK11A | 0.34040006 |
127 | PRKD2 | 0.34038729 |
128 | IRAK1 | 0.33900597 |
129 | TTK | 0.32081859 |
130 | SIK3 | 0.31122845 |
131 | BTK | 0.31010094 |
132 | PLK1 | 0.30893705 |
133 | RPS6KA5 | 0.30247902 |
134 | MAP3K1 | 0.30076633 |
135 | MAPK4 | 0.27675608 |
136 | MAP3K7 | 0.26917464 |
137 | PAK3 | 0.25814550 |
138 | CAMK2G | 0.25255883 |
139 | TAOK3 | 0.24954771 |
140 | GSK3A | 0.24250459 |
141 | CDK19 | 0.23716170 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Sulfur relay system_Homo sapiens_hsa04122 | 3.18250044 |
2 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.62447273 |
3 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.55683882 |
4 | Ribosome_Homo sapiens_hsa03010 | 2.45571927 |
5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.44791929 |
6 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.40604585 |
7 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.33252269 |
8 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.23297649 |
9 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.22403044 |
10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.17609939 |
11 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.16043189 |
12 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.09327323 |
13 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.06640249 |
14 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.06347313 |
15 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.04597653 |
16 | Selenocompound metabolism_Homo sapiens_hsa00450 | 2.01259457 |
17 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.92882189 |
18 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.90178319 |
19 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.88053808 |
20 | * Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.84279717 |
21 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.84089360 |
22 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.80352054 |
23 | * Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.79295018 |
24 | * VEGF signaling pathway_Homo sapiens_hsa04370 | 1.77964054 |
25 | * B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.68267136 |
26 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.68102999 |
27 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.64624537 |
28 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.64471504 |
29 | Carbon metabolism_Homo sapiens_hsa01200 | 1.63450877 |
30 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.62899461 |
31 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.59507661 |
32 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.58345047 |
33 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.56777307 |
34 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.50001131 |
35 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.48830456 |
36 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.43985020 |
37 | * Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.42707492 |
38 | Peroxisome_Homo sapiens_hsa04146 | 1.41674922 |
39 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.39682864 |
40 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.39130939 |
41 | * Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.37974882 |
42 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.37943715 |
43 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.36408543 |
44 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.35723504 |
45 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.35616563 |
46 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.35206217 |
47 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.34126379 |
48 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.33729683 |
49 | * Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.32017226 |
50 | Histidine metabolism_Homo sapiens_hsa00340 | 1.29912392 |
51 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.28679893 |
52 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.26964211 |
53 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.23099948 |
54 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.22778695 |
55 | * Prion diseases_Homo sapiens_hsa05020 | 1.21945685 |
56 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.20417355 |
57 | * Insulin signaling pathway_Homo sapiens_hsa04910 | 1.20179472 |
58 | * Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.18574898 |
59 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.18508451 |
60 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.17399799 |
61 | Leishmaniasis_Homo sapiens_hsa05140 | 1.15252897 |
62 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.14552458 |
63 | Proteasome_Homo sapiens_hsa03050 | 1.14045726 |
64 | * Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.12867936 |
65 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.12656582 |
66 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.12343818 |
67 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.11538623 |
68 | Galactose metabolism_Homo sapiens_hsa00052 | 1.10955231 |
69 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.10825382 |
70 | Lysosome_Homo sapiens_hsa04142 | 1.10616455 |
71 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.06618267 |
72 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.05218352 |
73 | * Glioma_Homo sapiens_hsa05214 | 1.04883469 |
74 | * GnRH signaling pathway_Homo sapiens_hsa04912 | 1.04364554 |
75 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.04295739 |
76 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.04000215 |
77 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.03832643 |
78 | DNA replication_Homo sapiens_hsa03030 | 1.03090885 |
79 | Hepatitis C_Homo sapiens_hsa05160 | 1.02818378 |
80 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.01842197 |
81 | Endocytosis_Homo sapiens_hsa04144 | 1.01079442 |
82 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.00170059 |
83 | Focal adhesion_Homo sapiens_hsa04510 | 0.98679682 |
84 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.97975439 |
85 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.97753018 |
86 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.97713756 |
87 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.97510279 |
88 | * Endometrial cancer_Homo sapiens_hsa05213 | 0.97162472 |
89 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.96856978 |
90 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.96283615 |
91 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.95775599 |
92 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.95578849 |
93 | Parkinsons disease_Homo sapiens_hsa05012 | 0.95293309 |
94 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.95114019 |
95 | * Renal cell carcinoma_Homo sapiens_hsa05211 | 0.94731162 |
96 | Amoebiasis_Homo sapiens_hsa05146 | 0.94458533 |
97 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.94275615 |
98 | * ErbB signaling pathway_Homo sapiens_hsa04012 | 0.92462120 |
99 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.91954077 |
100 | Salmonella infection_Homo sapiens_hsa05132 | 0.91783940 |
101 | Tuberculosis_Homo sapiens_hsa05152 | 0.91766807 |
102 | * Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.91464383 |
103 | * Apoptosis_Homo sapiens_hsa04210 | 0.91324446 |
104 | * Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.87928533 |
105 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.87587602 |
106 | Lysine degradation_Homo sapiens_hsa00310 | 0.87159245 |
107 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.87025465 |
108 | Bile secretion_Homo sapiens_hsa04976 | 0.85768455 |
109 | Insulin resistance_Homo sapiens_hsa04931 | 0.84392659 |
110 | RNA polymerase_Homo sapiens_hsa03020 | 0.83378837 |
111 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.83223779 |
112 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.83133601 |
113 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.82055585 |
114 | Shigellosis_Homo sapiens_hsa05131 | 0.80797485 |
115 | HTLV-I infection_Homo sapiens_hsa05166 | 0.80764921 |
116 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.78405238 |
117 | Viral myocarditis_Homo sapiens_hsa05416 | 0.78354836 |
118 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.77443687 |
119 | * Hepatitis B_Homo sapiens_hsa05161 | 0.77246503 |
120 | * Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.76566247 |
121 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.76469199 |
122 | * Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.75798112 |
123 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.75572236 |
124 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.74687468 |
125 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.74603002 |
126 | * Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.74457768 |
127 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.73638106 |
128 | * Influenza A_Homo sapiens_hsa05164 | 0.72628377 |
129 | Metabolic pathways_Homo sapiens_hsa01100 | 0.72327729 |
130 | Retinol metabolism_Homo sapiens_hsa00830 | 0.70103576 |
131 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.69273588 |
132 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.69138514 |
133 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.68789292 |
134 | * T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.68697455 |
135 | Malaria_Homo sapiens_hsa05144 | 0.67381846 |
136 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.67340829 |
137 | * MAPK signaling pathway_Homo sapiens_hsa04010 | 0.66382078 |
138 | Protein export_Homo sapiens_hsa03060 | 0.64862338 |
139 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.64830463 |
140 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.64005698 |
141 | ABC transporters_Homo sapiens_hsa02010 | 0.61931898 |
142 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.61449055 |
143 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.61424981 |
144 | Spliceosome_Homo sapiens_hsa03040 | 0.60740378 |
145 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.60456121 |
146 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.59412927 |
147 | * Long-term potentiation_Homo sapiens_hsa04720 | 0.59020023 |
148 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.58350177 |
149 | Colorectal cancer_Homo sapiens_hsa05210 | 0.58227393 |
150 | * Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.58113413 |
151 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.57313590 |
152 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.56802883 |
153 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.56772080 |
154 | * HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.55247494 |
155 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.54630236 |
156 | Base excision repair_Homo sapiens_hsa03410 | 0.54110115 |
157 | * Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.54066602 |
158 | Huntingtons disease_Homo sapiens_hsa05016 | 0.52153984 |
159 | * Prostate cancer_Homo sapiens_hsa05215 | 0.50443151 |
160 | * Thyroid cancer_Homo sapiens_hsa05216 | 0.50120185 |
161 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.49051327 |
162 | * Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.48786077 |
163 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.48567111 |
164 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.47705623 |
165 | * Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.47031660 |
166 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.46513042 |
167 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.46403061 |
168 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.46375572 |
169 | Other glycan degradation_Homo sapiens_hsa00511 | 0.45520311 |
170 | * Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.43931627 |
171 | * Bladder cancer_Homo sapiens_hsa05219 | 0.42827763 |
172 | Mismatch repair_Homo sapiens_hsa03430 | 0.42155821 |
173 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.41388885 |
174 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.39811388 |
175 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.39276586 |
176 | Alzheimers disease_Homo sapiens_hsa05010 | 0.38399655 |
177 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.37925061 |
178 | RNA transport_Homo sapiens_hsa03013 | 0.34530278 |
179 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.33948759 |
180 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.32370984 |
181 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.31767602 |
182 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.29078667 |
183 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.28461817 |
184 | Purine metabolism_Homo sapiens_hsa00230 | 0.28243655 |